Taysha Gene Therapies, Inc. · NASDAQ:TSHA
Donenberg Phillip B. received 21,335 Taysha Gene Therapies, Inc. shares as an award (Form 4)
Traded Jun 1, 2026 · Filed Jun 2, 2026
On Jun 1, 2026, Donenberg Phillip B. (Director) received 21,335 Taysha Gene Therapies, Inc. shares as an award, leaving 241,289 shares. Filed Jun 2, 2026 (Form 4).
- Awarded
- 21,335 shares
- Holding after
- 241,289 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Award | 21,335 | 241,289 | Direct |
Source
Related
- Taysha Gene Therapies, Inc.
- Donenberg Phillip B.
- Taysha Gene Therapies, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Form 4 · Nagendran Sukumar · Jul 10, 2026
- Form 4 · Stalfort John A III · Jun 2, 2026
- Form 4 · Long Alison S · Jun 2, 2026